| translation | GO:0006412 | 93 | 0.557 | |
| amp metabolic process | GO:0046033 | 4 | 0.211 | |
| regulation of translation | GO:0006417 | 71 | 0.190 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.149 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.145 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.126 | |
| methylation | GO:0032259 | 134 | 0.118 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.094 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.087 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.083 | |
| amp biosynthetic process | GO:0006167 | 2 | 0.082 | |
| oxidation reduction process | GO:0055114 | 342 | 0.076 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.075 | |
| multicellular organism growth | GO:0035264 | 161 | 0.075 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.074 | |
| rna processing | GO:0006396 | 105 | 0.067 | |
| protein methylation | GO:0006479 | 81 | 0.066 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.065 | |
| nuclear export | GO:0051168 | 34 | 0.064 | |
| protein folding | GO:0006457 | 28 | 0.062 | |
| ribonucleoprotein complex disassembly | GO:0032988 | 3 | 0.058 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.057 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.057 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.051 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.051 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.051 | |
| positive regulation of nucleocytoplasmic transport | GO:0046824 | 30 | 0.050 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.049 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.049 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.048 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.047 | |
| macromolecule methylation | GO:0043414 | 120 | 0.046 | |
| organelle disassembly | GO:1903008 | 2 | 0.044 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.043 | |
| regulation of protein localization | GO:0032880 | 231 | 0.042 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.042 | |
| regionalization | GO:0003002 | 337 | 0.042 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.041 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.040 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.040 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.040 | |
| response to oxidative stress | GO:0006979 | 123 | 0.040 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.039 | |
| translational initiation | GO:0006413 | 24 | 0.038 | |
| amine metabolic process | GO:0009308 | 45 | 0.038 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.038 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.038 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.037 | |
| lateral inhibition | GO:0046331 | 1 | 0.036 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.036 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.036 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.036 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.035 | |
| positive regulation of translation | GO:0045727 | 19 | 0.035 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.035 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.035 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.034 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.034 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.034 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.034 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.034 | |
| positive regulation of transcription from rna polymerase i promoter | GO:0045943 | 3 | 0.034 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.033 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.033 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.032 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.031 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.031 | |
| intracellular protein transport | GO:0006886 | 204 | 0.030 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.030 | |
| dna metabolic process | GO:0006259 | 303 | 0.030 | |
| spermatogenesis | GO:0007283 | 284 | 0.029 | |
| germ cell development | GO:0007281 | 185 | 0.029 | |
| maternal process involved in female pregnancy | GO:0060135 | 32 | 0.029 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.029 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.029 | |
| regulation of translational initiation | GO:0006446 | 15 | 0.029 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.029 | |
| embryonic placenta development | GO:0001892 | 98 | 0.028 | |
| endocytosis | GO:0006897 | 168 | 0.028 | |
| ribonucleoside biosynthetic process | GO:0042455 | 21 | 0.028 | |
| compound eye development | GO:0048749 | 1 | 0.027 | |
| nuclear transport | GO:0051169 | 139 | 0.027 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.027 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.026 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.026 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.026 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.026 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.025 | |
| protein alkylation | GO:0008213 | 81 | 0.025 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.025 | |
| termination of rna polymerase ii transcription | GO:0006369 | 1 | 0.025 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.025 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.025 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.025 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.025 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.025 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.025 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.024 | |
| negative regulation of translation | GO:0017148 | 22 | 0.024 | |
| protein targeting | GO:0006605 | 143 | 0.024 | |
| chromatin organization | GO:0006325 | 206 | 0.023 | |
| ribosome biogenesis | GO:0042254 | 20 | 0.023 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.023 | |
| sensory perception | GO:0007600 | 245 | 0.023 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.023 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.022 | |
| lung development | GO:0030324 | 164 | 0.022 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.022 | |
| segmentation | GO:0035282 | 93 | 0.022 | |
| protein maturation | GO:0051604 | 176 | 0.022 | |
| histone modification | GO:0016570 | 159 | 0.021 | |
| endomembrane system organization | GO:0010256 | 147 | 0.021 | |
| ribosomal small subunit biogenesis | GO:0042274 | 4 | 0.021 | |
| spermatid differentiation | GO:0048515 | 115 | 0.021 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.021 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.020 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.020 | |
| protein import into nucleus | GO:0006606 | 95 | 0.020 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.020 | |
| skeletal system development | GO:0001501 | 356 | 0.020 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.020 | |
| maintenance of location | GO:0051235 | 89 | 0.020 | |
| transdifferentiation | GO:0060290 | 1 | 0.020 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.020 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.020 | |
| organelle localization | GO:0051640 | 179 | 0.020 | |
| macromolecular complex disassembly | GO:0032984 | 43 | 0.019 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.019 | |
| action potential | GO:0001508 | 78 | 0.019 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.019 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.019 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.019 | |
| sensory perception of pain | GO:0019233 | 47 | 0.018 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.018 | |
| purine nucleoside biosynthetic process | GO:0042451 | 19 | 0.018 | |
| chromatin modification | GO:0016568 | 187 | 0.018 | |
| rna catabolic process | GO:0006401 | 29 | 0.018 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.017 | |
| innate immune response | GO:0045087 | 157 | 0.017 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.017 | |
| organelle fission | GO:0048285 | 170 | 0.017 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.017 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.017 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.017 | |
| b cell activation | GO:0042113 | 161 | 0.017 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.017 | |
| cation homeostasis | GO:0055080 | 212 | 0.017 | |
| cellular response to arsenic containing substance | GO:0071243 | 4 | 0.017 | |
| respiratory system development | GO:0060541 | 190 | 0.017 | |
| inflammatory response | GO:0006954 | 244 | 0.017 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.017 | |
| regulation of defense response | GO:0031347 | 233 | 0.017 | |
| cellular homeostasis | GO:0019725 | 240 | 0.017 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.017 | |
| cellular protein complex disassembly | GO:0043624 | 36 | 0.017 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.017 | |
| placenta development | GO:0001890 | 140 | 0.017 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.016 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.016 | |
| spermatid development | GO:0007286 | 108 | 0.016 | |
| glycosyl compound biosynthetic process | GO:1901659 | 21 | 0.016 | |
| polysaccharide metabolic process | GO:0005976 | 39 | 0.016 | |
| protein desumoylation | GO:0016926 | 2 | 0.016 | |
| nuclear division | GO:0000280 | 158 | 0.016 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.016 | |
| forebrain development | GO:0030900 | 302 | 0.016 | |
| ossification | GO:0001503 | 216 | 0.016 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.016 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.016 | |
| cardiac muscle cell contraction | GO:0086003 | 7 | 0.016 | |
| regulation of protein transport | GO:0051223 | 163 | 0.015 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.015 | |
| chromosome segregation | GO:0007059 | 48 | 0.015 | |
| connective tissue development | GO:0061448 | 179 | 0.015 | |
| maternal placenta development | GO:0001893 | 20 | 0.015 | |
| dendrite development | GO:0016358 | 115 | 0.015 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.015 | |
| myosin filament organization | GO:0031033 | 3 | 0.015 | |
| 3 utr mediated mrna stabilization | GO:0070935 | 2 | 0.015 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.015 | |
| somitogenesis | GO:0001756 | 69 | 0.015 | |
| gastrulation | GO:0007369 | 116 | 0.015 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.015 | |
| transmembrane transport | GO:0055085 | 412 | 0.015 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.015 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.015 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.015 | |
| protein localization to organelle | GO:0033365 | 185 | 0.015 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.015 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.015 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.015 | |
| mrna metabolic process | GO:0016071 | 84 | 0.015 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.015 | |
| neural tube development | GO:0021915 | 160 | 0.015 | |
| learning or memory | GO:0007611 | 148 | 0.015 | |
| cytokine production involved in inflammatory response | GO:0002534 | 9 | 0.014 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.014 | |
| positive regulation of protein export from nucleus | GO:0046827 | 4 | 0.014 | |
| neuron death | GO:0070997 | 154 | 0.014 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.014 | |
| cation transport | GO:0006812 | 399 | 0.014 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.014 | |
| polyamine biosynthetic process | GO:0006596 | 2 | 0.014 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.014 | |
| lipid localization | GO:0010876 | 126 | 0.014 | |
| membrane organization | GO:0061024 | 245 | 0.014 | |
| purine ribonucleoside biosynthetic process | GO:0046129 | 19 | 0.014 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.014 | |
| negative regulation of purine nucleotide catabolic process | GO:0033122 | 9 | 0.014 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.014 | |
| regulation of transcription from rna polymerase i promoter | GO:0006356 | 6 | 0.014 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.014 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.013 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.013 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.013 | |
| cellular biogenic amine metabolic process | GO:0006576 | 28 | 0.013 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.013 | |
| blood circulation | GO:0008015 | 195 | 0.013 | |
| dna repair | GO:0006281 | 107 | 0.013 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.013 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.013 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.013 | |
| nucleus organization | GO:0006997 | 45 | 0.013 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.013 | |
| response to inorganic substance | GO:0010035 | 96 | 0.013 | |
| angiogenesis | GO:0001525 | 201 | 0.013 | |
| response to nutrient levels | GO:0031667 | 109 | 0.013 | |
| regulation of cell migration | GO:0030334 | 219 | 0.013 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.013 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.013 | |
| actin mediated cell contraction | GO:0070252 | 15 | 0.013 | |
| male gamete generation | GO:0048232 | 285 | 0.013 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.012 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.012 | |
| nucleoside biosynthetic process | GO:0009163 | 21 | 0.012 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.012 | |
| cartilage development | GO:0051216 | 140 | 0.012 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.012 | |
| regulation of ion transport | GO:0043269 | 215 | 0.012 | |
| ear development | GO:0043583 | 200 | 0.012 | |
| rna interference | GO:0016246 | 2 | 0.012 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.012 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.012 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.012 | |
| respiratory tube development | GO:0030323 | 167 | 0.012 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.012 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.012 | |
| endoplasmic reticulum localization | GO:0051643 | 2 | 0.012 | |
| protein complex disassembly | GO:0043241 | 40 | 0.012 | |
| circulatory system process | GO:0003013 | 197 | 0.012 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.012 | |
| oogenesis | GO:0048477 | 56 | 0.012 | |
| positive regulation of cytoplasmic transport | GO:1903651 | 40 | 0.012 | |
| negative regulation of apoptotic cell clearance | GO:2000426 | 1 | 0.012 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.012 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.012 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.012 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.011 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.011 | |
| gonad development | GO:0008406 | 141 | 0.011 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.011 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.011 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.011 | |
| neural tube formation | GO:0001841 | 108 | 0.011 | |
| mitotic nuclear division | GO:0007067 | 48 | 0.011 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.011 | |
| phagocytosis | GO:0006909 | 66 | 0.011 | |
| trna wobble base modification | GO:0002097 | 2 | 0.011 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.011 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.011 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.011 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.011 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.011 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.011 | |
| male gonad development | GO:0008584 | 88 | 0.011 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.011 | |
| mrna catabolic process | GO:0006402 | 22 | 0.011 | |
| rrna containing ribonucleoprotein complex export from nucleus | GO:0071428 | 1 | 0.011 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.011 | |
| regulation of cell motility | GO:2000145 | 236 | 0.011 | |
| negative regulation of nucleotide metabolic process | GO:0045980 | 16 | 0.011 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.011 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.011 | |
| hexose metabolic process | GO:0019318 | 98 | 0.011 | |
| positive regulation of protein import into nucleus | GO:0042307 | 26 | 0.011 | |
| regulation of cell division | GO:0051302 | 76 | 0.011 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.011 | |
| ventricular system development | GO:0021591 | 27 | 0.011 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.010 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.010 | |
| neuronal action potential | GO:0019228 | 54 | 0.010 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.010 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.010 | |
| stem cell development | GO:0048864 | 219 | 0.010 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.010 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.010 | |
| ribonucleoprotein complex localization | GO:0071166 | 1 | 0.010 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.010 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.010 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.010 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.010 | |
| striated muscle contraction | GO:0006941 | 45 | 0.010 | |
| dna templated transcriptional preinitiation complex assembly | GO:0070897 | 4 | 0.010 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.010 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.010 | |
| signal transduction involved in cell cycle checkpoint | GO:0072395 | 3 | 0.010 | |
| cell cycle g1 s phase transition | GO:0044843 | 57 | 0.010 | |
